Biomarker for sensitivity to mTOR inhibitor therapy in kidney cancer

Details for Australian Patent Application No. 2006227393 (hide)

Owner The Regents of The University of California

Inventors Sawyers, Charles L.; Thomas, George V.

Agent Griffith Hack

Pub. Number AU-B-2006227393

PCT Pub. Number WO2006/102111

Priority 60/662,649 17.03.05 US

Filing date 17 March 2006

Wipo publication date 28 September 2006

Acceptance publication date 21 April 2011

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

8 November 2007 PCT application entered the National Phase

  PCT publication WO2006/102111 Priority application(s): WO2006/102111

21 April 2011 Application Accepted

  Published as AU-B-2006227393

18 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006227394-Prokineticin 1 receptor

2006227390-Fucoidan compositions and methods for dietary and nutritional supplements